Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
Illumina $1 billion notes offering
The investment-grade notes are due 2027
Prometheus Biosciences $500 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing
Lantheus Holdings $575 million convertible senior notes offering
The 2.625% convertible notes are due 2027
IVERIC bio $324.7 million stock offering
The shares are listed on the Nasdaq Global Select Market
Biodesix $40 million follow-on offering
The shares are listed on the Nasdaq Global Market
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange